# Botswana Smoking and Abstinence Reinforcement Trial

> **NCT05694637** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **University of Maryland, Baltimore** · enrollment: 750 (estimated)

## Conditions studied

- Smoking Cessation
- Hiv

## Interventions

- **BEHAVIORAL:** Screening, Brief Intervention and Referral to Treatment (SBIRT) intervention consisting of the 5As, (Ask, Advise, Assess, Assist, Arrange)
- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT05694637
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-07-25
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-08-31
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2026-01-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05694637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05694637, "Botswana Smoking and Abstinence Reinforcement Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05694637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
